Ultragenyx Pharmaceutical Inc (0LIF)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 133k | 2.61M | 51.5M | 103.71M | 271.03M | 351.41M | 363.33M | 434.25M |
| Operating Income | -248.01M | -328.94M | -371.37M | -424.17M | -330.12M | -381.74M | -648.92M | -569.21M |
| Pre Tax Income | -245.84M | -318.34M | -197.1M | -399.44M | -185.36M | -452.98M | -701.73M | -608.46M |
| Net Income | -245.87M | -302.14M | -197.61M | -402.73M | -186.57M | -454.03M | -707.42M | -606.64M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -5.962 | -6.841 | -3.885 | -6.963 | -2.792 | -6.547 | -10.078 | -7.388 |
| EBIT | -249.63M | -322.41M | -206.64M | -424.96M | -329.51M | -383.42M | -650.49M | -569.55M |
| EBITDA | -244.58M | -323.12M | -351.84M | -415.63M | -317.86M | -368.51M | -630.7M | -543.2M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
